Evaluation of a Patient Portal Intervention to Address Diabetes Care Gaps (NCT04728620) | Clinical Trial Compass
CompletedNot Applicable
Evaluation of a Patient Portal Intervention to Address Diabetes Care Gaps
United States60 participantsStarted 2021-05-06
Plain-language summary
The purpose of this study is to evaluate the usability of a novel patient portal intervention designed to: (a) notify patients when selected, clinically meaningful, evidence-based diabetes monitoring \& preventative care (e.g., annual diabetes eye exam) become due and (b) allow patients to initiate orders for the care. In addition, the investigators will assess pre-post change on secondary psychosocial outcomes (e.g., self-efficacy).
Who can participate
Age range18 Years – 75 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Established patient at participating primary care clinic
* Type 1 or 2 diabetes mellitus
* Able to speak and read in English
* Age 18 to 75 years old
* Mobile device (smartphone or tablet) with internet access
* Active MHAV account and willing and able to use the MHAV native app on a mobile device
* Due (based on evidence-based guidelines) for any of the following: hemoglobin A1C, urine microalbumin, diabetes eye exam, and/or pneumococcal vaccination.
Exclusion Criteria:
* Known cognitive deficits or functional impairment preventing the use of a mobile device
* Pregnant or planning to become pregnant during the study period
* Severe difficulty seeing
* Severe difficulty hearing
* Medical condition that make it hard for people to understand what they are saying
What they're measuring
1
Usability
Timeframe: Immediately after first use T(1), at approximately 1 month